Basic Information
ID: ALA4362017
Type: Functional
Description: Antagonist activity at human P2Y14R stably expressed in human forskolin treated THP1 cells assessed as reduction in P2Y14R agonist UDPG-induced inhibition of cAMP production at 100 nM incubated for 15 mins by competitive enzyme-linked immunoassay relative to control
Organism: Homo sapiens
Activity Charts
Bioactivity
Activity Types for Assay ALA4362017
Inhibition
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 475.51 | 7.36 | 7.36 |
| 414.51 | 5.08 | 5.08 |
| 434.92 | 5.42 | 5.42 |
| 420.53 | 5.14 | 5.14 |
| 428.53 | 5.33 | 5.33 |
| 392.50 | 4.65 | 4.65 |
| 401.47 | 4.17 | 4.17 |
| 418.47 | 4.91 | 4.91 |
| 425.49 | 4.64 | 4.64 |
| 400.48 | 4.77 | 4.77 |
| 484.47 | 5.67 | 5.67 |
| 404.47 | 4.67 | 4.67 |
| 378.47 | 4.26 | 4.26 |
| 479.37 | 5.53 | 5.53 |
| 364.45 | 3.87 | 3.87 |
| 445.48 | 4.68 | 4.68 |
| 402.45 | 3.56 | 3.56 |
| 390.44 | 4.36 | 4.36 |
| 468.48 | 5.79 | 5.79 |
| 444.49 | 4.50 | 4.50 |
| 430.50 | 4.78 | 4.78 |
| 401.47 | 4.17 | 4.17 |
| 442.56 | 5.89 | 5.89 |
| 406.51 | 4.83 | 4.83 |